Abstract
Osteoarthritis (OA) and Rheumatoid arthritis (RA) are major inflammatory diseases occurring across the globe, mostly in developing countries. The transdermal drug delivery system (TDDS) has opened up a new form of application for the delivery of the drugs, avoiding side effects like gastrointestinal tract (GIT) disturbances in patients, which are basically caused due to oral administrations. In the present review, new treatment strategies for aforementioned both diseases have been covered concerning TDDS approach. Several recent studies have been summarized focusing on the management of OA and RA through TDDS; among which micro-needles and transdermal patches have shown the most excellent prospects and have also been considered the new-fangled and advanced means of anti-inflammatory drugs' delivery. In this piece of writing, we have discussed varied types of transdermal drug delivery systems that have been developed in recent years for the management of and also the betterment of the life of patients suffering from OA and RA.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
